All attending UK organisations

UK companies attending Bio Convention 2018 *

(Click here to search profiles):

UK Pavilion and Regional Groups:
Alderley Park, Conversis, CRNCC,   Exploristics, Global Regulatory Services, London & Partners, MedCity, Midlands Engine, Northern Health Science Alliance, ProAxsis, Quay Pharmaceuticals, QUB, Reliance, Ulster University

Other UK companies associated with the delegation*:
Alacrita Holdings, Biotech and Money, Celentyx, CIMYM Biosciences, Crystec, Medherant, Novintum Bioscience, Pneumagen, Therakind, XenoGesis

All attending UK companies:
4d Pharma, Abcam, Abzena, Acacia Pharma, Accretio, Action On Hearing Loss, Agilinx Therapeutics, Albumedix, Alderley Park, Almac Discovery, ALSA Holdings, Apex Healthcare Consulting, Apitope International, Aptus Clinical, ARCINOVA, Arecor, Astex Pharmaceuticals, AstraZeneca & MedImmune, Aurum Biosciences, Avacta Life Sciences, Avidity IP, Avillion, Bactevo, BBI Solutions, BenevolentAI, BioClavis, UK Bioindustry Association (BIA), Biotech and Money, Bird & Bird, Blueberry Therapeutics, Buchner, C4x Discovery, Calchan, Cambridge Enterprise, Cancer Research UK, Capella Bioscience, Celentyx, Cell Guidance Systems, Cell Medica, Censo Biotechnologies, Centre of Excellence in Infectious Diseases Research, CIMYM BioSciences, Circassia, Clinical Accelerator, CMAC, CN Bio Innovations, Cobra Biologics, Concept Life Sciences, Consilient Health, Conversis, Crescendo Biologics, Cresset, CRNCC, Crystec Pharma, Datatrial, UK Department for International Trade, Diamond Pharma Services, DPS Group, Elasmogen, Enesi Pharma, Ergomed, E-Therapeutics, Exploristics, Finvector Vision Therapies, F-Star, Fusion Antibodies, GlaxoSmithKline, GlobalData, Global Regulatory Services, Glythera, Gowling WLG, Haoma Medica, Hikma Pharmaceuticals, Horizon Discovery, Illingworth Research Group, Image Analysis Group, ImmBio, Imperial Innovations, Inceptua Medicines Access, Innovate UK, Instinctif Partners, Intract Pharma, Invest Northern Ireland, Iontas, Karma Oncology, KDH BioManagement, Kymab, Kyowa Kirin International, LifeArc, Locate Therapeutics, Locust Walk Europe, London & Partners, Mallinckrodt Pharmaceuticals, Masters Speciality Pharma, Maucher Jenkins, Mawdsley-Brooks, MedCity, Medherant, Medical Research Network, Medicines Evaluation Unit, MedPharm, Mereo BioPharma, metaLinear, Micromatrices, Midatech Pharma, Midlands UK, Molecular Warehouse, Mundipharma International, Nanogenics, NDA Group, NHS Research Scotland, NIHR Clinical Research Network, NMR Rothschild & Co, Norgine Ventures, Northern Health Science Alliance, Novabiotics, Novarum DX, Novintum Bioscience, O2h, OBN (UK), Oncimmune, Oppilotech, Oval Medical Technologies, Oxford BioMedica, Oxford Genetics, Oxford University Innovation, OxStem, Oxyrane, PharmaVentures, PrEP Biopharm, ProAxsis, ProteinLogic, Proventa International, Psioxus Therapeutics, QuantuMDx, Quay Pharmaceuticals, QUB, Random42, Randox Biosciences, Redx Pharma, Reliance, REPROCELL, Results Healthcare, Sareum, SBA, Scancell, Sekisui Diagnostics, Shield Therapeutics, Silence Therapeutics, Simbec-Orion Group, Sisaf, Solid Form Solutions, Springer Nature, Stabilitech, Summit Therapeutics, Symbiosis Pharmaceutical Services, Synpromics, SYNthesis Research, TC Biopharm, The AMR Centre, The Institute of Cancer Research, The NHSA, The Wellcome Trust Sanger Institute, Theradex, Therakind, Theramex, TISSUE SOLUTIONS, TopiVert Pharma, Transcrip Partners, Treehill Partners, TwistDx, Ubiquigent, Ulster University, University of Bath, University of Dundee - Drug Discovery Unit, University of Edinburgh, University of Nottingham, University of Oxford, Vaccitech, Vectura Group, Veriton Pharma, Viiv Healthcare, Viramal,VirdisGroup, Vygoris, Welsh Government, World Courier, XenoGesis, Yakumed.

Join them here!

* supported by UK Department for International Trade